In: Analytical and Bioanalytical Chemistry, 2015, vol. 407, no. 18, p. 5425-5432
|
In: Angiogenesis, 2015, vol. 18, no. 3, p. 327-345
|
In: Cancer Immunology, Immunotherapy, 2015, vol. 64, no. 8, p. 1033-1046
|
In: Cancer and Metastasis Reviews, 2014, vol. 33, no. 1, p. 183-215
|
In: Cell and Tissue Research, 2003, vol. 314, no. 1, p. 167-177
|
In: Journal of Mammary Gland Biology and Neoplasia, 2010, vol. 15, no. 3, p. 341-352
|
In: Angiogenesis, 2013, vol. 16, no. 4, p. 795-807
|
In: Angiogenesis, 2015, vol. 18, no. 3, p. 327–345
Tumor growth depends on the formation of new blood vessels (tumor angiogenesis) either from preexisting vessels or by the recruitment of bone marrow-derived cells. Despite encouraging results obtained with preclinical cancer models, the therapeutic targeting of tumor angiogenesis has thus far failed to deliver an enduring clinical response in cancer patients. One major obstacle for improving...
|